Jan. 11, 2013
-- CHICAGO, Ill. (January 11, 2013) – Variance Development Partners (VDP), a private growth investment group based in Chicago, Illinois, today announced that it closed its first fund, VDP-1. The fund will focus on making extended-term capital investments in established small to mid-sized firms that provide advisory services to developing pharmaceutical and medical device companies. A team of seasoned executives from the contract research, investment and healthcare industries will lead VDP’s investment strategy which concentrates on contract research organizations with strong success potential. VDP-1 will limit its investment offering to a few select companies each year to ensure that each one receives substantive hands-on attention and operational assistance.
“We’re excited by the opportunity that this new fund represents,”
said Patrick Flanagan, partner with Variance Development Partners. “The contract research market is one with tremendous potential. Small to mid-sized companies typically possess deep scientific talent yet lack meaningful resources for managing business operations. The goal of Variance Development Partners is to bring business management expertise to VDP portfolio companies and put them on a clear path to fast and steady growth for the future.”About Variance Development Partners
Variance Development Partners (VDP) is a private growth investment group that seeks to increase the value of its portfolio companies by providing investment and operational expertise that improves competitive positions and increases organizational efficiencies that impact growth. Its dual approach to investment infuses high potential companies with growth capital, and aligns financial and business strategies to ensure the best tactical resources are in place that enable these companies to thrive. Due to its high degree of direct involvement with its portfolio companies, VDP limits its investments each year to a few select companies. To learn more, please visit www.variancedp.com